Scorpius Holdings, Inc.

0.11 USD
+0.00 (+1.73%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Scorpius Holdings, Inc. stock is down -33.75% since 30 days ago. The next earnings date is Jun 4, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 10 May’s closed higher than April.

About Scorpius Holdings, Inc.

Heat Biologics, Inc. operates as a clinical-stage biopharmaceutical company, with interest in the development of novel allergenic drugs. The company focuses on the commercialization of ImPact Therapy, a platform technology that offers a novel approach to treat cancer and other infectious diseases, including HIV, HCV and malaria by using live, genetically-modified, and irradiated human cells to activate the immune system against specific defined targets. Heat Biologics was founded on June 10, 2008 by Jeffrey Alan Wolf and is headquartered in Durham, NC.